Component portfolio and prices


Portfolio of blood components and guidance (PDF 1.82MB)

This provides details of therapeutic blood components including constituents, and information on:

  • specifications
  • identification barcodes
  • quality standards and monitoring
  • storage and handling
  • clinical indications and contraindications
  • specialist requirements
  • dosage, administration, recognition of adverse effects
  • material safety data sheet



Availability of non stock and special components


UK sourced FFP and cryoprecipitate components for neonates and infants 

Since August 2020 these components have been manufactured to a revised specification to improve their quality for transfusion. This specification will be added to the component portfolio when it is next revised.